Inhibition of Skp2 Sensitizes Chronic Myeloid Leukemia Cells to Imatinib

par Chen, Xiaowen, Huang, Zhenqi, Wu, Wei, Xia, Ruixiang
Publié dans Cancer Manag Res (2020)

Functional role of regulatory T cells in B cell lymphoma and related mechanisms

par Wu, Wei, Wan, Jun, Xia, Ruixiang, Huang, Zhenqi, Ni, Jing, Yang, Mingzhen
Publié dans Int J Clin Exp Pathol (2015)

miR-337 suppresses cutaneous T-cell lymphoma via the STAT3 pathway

par Xia, Liang, Wu, Linlin, Xia, Hailong, Bao, Jing, Li, Qingsheng, Chen, Xiaowen, Xia, Ruixiang
Publié dans Cell Cycle (2019)

Long Non-coding RNA X-Inactive Specific Transcript Mediates Cell Proliferation and Intrusion by Modulating the miR-497/Bcl-w Axis in Extranodal Natural Killer/T-cell Lymphoma

par Liu, Qinhua, Ran, Ruonan, Wu, Zhengsheng, Li, Xiaodan, Zeng, Qingshu, Xia, Ruixiang, Wang, Yalei
Publié dans Front Cell Dev Biol (2020)

Plasma Levels of Interleukin 12 Family Cytokines and Their Relevant Cytokines in Adult Patients with Chronic Immune Thrombocytopenia before and after High-Dose Dexamethasome Treatm...

par Li, Qingsheng, Zhang, Linjie, Xia, Ruixiang, Zeng, Qingshu, Wang, Yongqing, Xia, Liang, Xia, Leiming, Yang, Mingzhen
Publié dans Med Princ Pract (2015)

Case Report: Local Cytokine Release Syndrome in an Acute Lymphoblastic Leukemia Patient After Treatment With Chimeric Antigen Receptor T-Cell Therapy: A Possible Model, Literature...

par Luan, Chengxin, Zhou, Junjie, Wang, Haixia, Ma, Xiaoyu, Long, Zhangbiao, Cheng, Xin, Chen, Xiaowen, Huang, Zhenqi, Zhang, Dagan, Xia, Ruixiang, Ge, Jian
Publié dans Front Immunol (2021)

Dual Effects of Cyclooxygenase Inhibitors in Combination With CD19.CAR-T Cell Immunotherapy

par Yang, Mingya, Wang, Lei, Ni, Ming, Neuber, Brigitte, Wang, Sanmei, Gong, Wenjie, Sauer, Tim, Schubert, Maria-Luisa, Hückelhoven-Krauss, Angela, Xia, Ruixiang, Ge, Jian, Kleist, Christian, Eckstein, Volker, Sellner, Leopold, Müller-Tidow, Carsten, Dreger, Peter, Schmitt, Michael, Schmitt, Anita
Publié dans Front Immunol (2021)

Selectively targeting FLT3-ITD mutants over FLT3- wt by a novel inhibitor for acute myeloid leukemia

par Wang, Aoli, Hu, Chen, Chen, Cheng, Liang, Xiaofei, Wang, Beilei, Zou, Fengming, Yu, Kailin, Li, Feng, Liu, Qingwang, Qi, Ziping, Wang, Junjie, Wang, Wenliang, Wang, Li, Weisberg, Ellen L., Wang, Wenchao, Li, Lili, Ge, Jian, Xia, Ruixiang, Liu, Jing, Liu, Qingsong
Publié dans Haematologica (2020)

Discovery and characterization of a novel highly potent and selective type II native and drug-resistant V299L mutant BCR-ABL inhibitor (CHMFL-ABL-039) for Chronic Myeloid Leukemia...

par Wu, Jiaxin, Wang, Aoli, Li, Xixiang, Chen, Cheng, Qi, Ziping, Hu, Chen, Wang, Wenliang, Wu, Hong, Huang, Tao, Zhao, Ming, Wang, Wenchao, Hu, Zhenquan, Liu, Qingwang, Wang, Beilei, Wang, Li, Li, Lili, Ge, Jian, Ren, Tao, Xia, Ruixiang, Liu, Jing, Liu, Qingsong
Publié dans Cancer Biol Ther (2019)

A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia

par Mei, Heng, Liu, Xiaofan, Li, Yan, Zhou, Hu, Feng, Ying, Gao, Guangxun, Cheng, Peng, Huang, Ruibin, Yang, Linhua, Hu, Jianda, Hou, Ming, Yao, Yazhou, Liu, Li, Wang, Yi, Wu, Depei, Zhang, Liansheng, Zheng, Changcheng, Shen, Xuliang, Hu, Qi, Liu, Jing, Jin, Jie, Luo, Jianmin, Zeng, Yun, Gao, Sujun, Zhang, Xiaohui, Zhou, Xin, Shi, Qingzhi, Xia, Ruixiang, Xie, Xiaobao, Jiang, Zhongxing, Gao, Li, Bai, Yuansong, Li, Yan, Xiong, Junye, Li, Runzi, Zou, Jianjun, Niu, Ting, Yang, Renchi, Hu, Yu
Publié dans J Hematol Oncol (2021)